Adjuvant therapy for patients with stage I papillary serous endometrial cancer

Rose, 1996, Endometrial Carcinoma, N Engl J Med, 335, 640, 10.1056/NEJM199608293350907 Creasman, 2003, Carcinoma of the corpus uteri, Int J Gynaecol Obstet, 83, 79, 10.1016/S0020-7292(03)90116-0 Kelly, 2005, Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy, Gynecol Oncol, 98, 353, 10.1016/j.ygyno.2005.06.012 Hendrickson, 1982, Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma, Am J Surg Pathol, 6, 93, 10.1097/00000478-198203000-00002 Gehrig, 2001, Noninvasive papillary serous carcinoma of the endometrium, Obstet Gynecol, 97, 153, 10.1016/S0029-7844(00)01096-6 Podratz, 2003, Uterine papillary serous carcinomas: the exigency for clinical trials, Gynecol Oncol, 91, 461, 10.1016/j.ygyno.2003.10.031 Goff, 1994, Uterine papillary serous carcinoma: patterns of metastatic spread, Gynecol Oncol, 54, 264, 10.1006/gyno.1994.1208 Creutzberg, 2000, Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial, Lancet, 355, 1404, 10.1016/S0140-6736(00)02139-5 Creasman, 2004, Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium, Gynecol Oncol, 95, 593, 10.1016/j.ygyno.2004.08.019 Kelly, 2004, Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation, Gynecol Oncol, 95, 469, 10.1016/j.ygyno.2004.08.030 ACOG practice bulletin, clinical management guidelines for obstetrician–gynecologists, number 65, 2005: management of endometrial cancer. Obstet Gynecol 2005;106:413–25. Chan, 2003, Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium, Gynecol Oncol, 90, 181, 10.1016/S0090-8258(03)00195-1 Slomovitz, 2003, Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases, Gynecol Oncol, 91, 463, 10.1016/j.ygyno.2003.08.018 Kwon, 2004, The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma, Int J Radiat Oncol Biol Phys, 59, 1439, 10.1016/j.ijrobp.2004.01.044 Lim, 2001, Early stage uterine papillary serous carcinoma of the endometrium, Cancer, 91, 752, 10.1002/1097-0142(20010215)91:4<752::AID-CNCR1061>3.0.CO;2-E Steed, 2003, Treatment of uterine papillary serous carcinoma with radiotherapy and chemotherapy, Proc Am Soc Clin Oncol, 453 Grice, 1998, Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients, Gynecol Oncol, 69, 69, 10.1006/gyno.1998.4956 Martin, 2005, Papillary serous carcinoma—a less radio-sensitive subtype of endometrial cancer, Gynecol Oncol, 98, 299, 10.1016/j.ygyno.2005.04.009 Zanotti, 1999, The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma, Gynecol Oncol, 74, 272, 10.1006/gyno.1999.5444 Rosenberg, 1993, A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer, Gynecol Oncol, 48, 32, 10.1006/gyno.1993.1006 Bancher-Todesca, 1998, Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma, Gynecol Oncol, 71, 344, 10.1006/gyno.1998.5202 Low, 2005, Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma, Gynecol Oncol, 97, 171, 10.1016/j.ygyno.2005.01.001 Craighead, 2000, Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994, Gynecol Oncol, 77, 248, 10.1006/gyno.2000.5746 Carcangiu, 1992, Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma, Gynecol Oncol, 47, 298, 10.1016/0090-8258(92)90130-B Zheng, 2005, Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management, Gynecol Oncol, 96, 579, 10.1016/j.ygyno.2004.12.045 Goff, 2005, Uterine papillary serous carcinoma: what have we learned over the past quarter century?, Gynecol Oncol, 98, 341, 10.1016/j.ygyno.2005.07.006 Turner, 1998, Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy, Int J Radiat Oncol Biol Phys, 40, 77, 10.1016/S0360-3016(97)00581-6 Huh, 2003, Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy, Gynecol Oncol, 91, 470, 10.1016/j.ygyno.2003.08.027 Price, 1993, Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC), Gynecol Oncol, 51, 383, 10.1006/gyno.1993.1308 Chambers, 1996, Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide, Gynecol Oncol, 60, 438, 10.1006/gyno.1996.0070